Rekabdar Elham, Tunbäck Petra, Liljeqvist Jan-Ake, Lindh Magnus, Bergström Tomas
Department of Clinical Virology, Göteborg University, Göteborg, Sweden.
J Clin Microbiol. 2002 Sep;40(9):3245-51. doi: 10.1128/JCM.40.9.3245-3251.2002.
Herpes simplex virus type 1 (HSV-1) encodes 11 envelope glycoproteins, of which glycoprotein G-1 (gG-1) induces a type-specific antibody response. Variability of the gG-1 gene among wild-type strains may be a factor of importance for a reliable serodiagnosis and typing of HSV-1 isolates. Here, we used a gG-1 type-specific monoclonal antibody (MAb) to screen for mutations in the immunodominant region of this protein in 108 clinical HSV-1 isolates. Of these, 42 isolates showed no reactivity to the anti-gG-1 MAb. One hundred five strains were further examined by DNA sequencing of the middle part of the gG-1 gene, encompassing 106 amino acids including the immunodominant region and epitope of the anti-gG-1 MAb. By phylogenetic comparisons based on the sequence data, we observed two (main) genetic variants of the gG-1 gene among the clinical isolates corresponding to reactivity or nonreactivity to the anti-gG-1 MAb. Furthermore, four strains appeared to be recombinants of the two gG-1 variants. In addition, one strain displayed a gG-1-negative phenotype due to a frameshift mutation, in the form of insertion of a cytosine nucleotide. When immunoglobulin G reactivity to HSV-1 in sera from patients infected with either of the two variants was investigated, no significant differences were found between the two groups, either in a type-common enzyme-linked immunosorbent assay (ELISA) or in a type-specific gG-1 antigen-based ELISA. Despite the here-documented existence of two variants of the gG-1 gene affecting the immunodominant region of the protein, other circumstances, such as early phase of infection, might be sought for explaining the seronegativity to gG-1 commonly found in a proportion of the HSV-1-infected patients.
单纯疱疹病毒1型(HSV-1)编码11种包膜糖蛋白,其中糖蛋白G-1(gG-1)可诱导型特异性抗体反应。野生型毒株中gG-1基因的变异性可能是HSV-1分离株可靠血清学诊断和分型的重要因素。在此,我们使用gG-1型特异性单克隆抗体(MAb)筛选108株临床HSV-1分离株中该蛋白免疫显性区域的突变。其中,42株分离株与抗gG-1 MAb无反应性。通过对gG-1基因中部进行DNA测序,对105株毒株进行了进一步检测,该区域包含106个氨基酸,包括抗gG-1 MAb的免疫显性区域和表位。基于序列数据进行系统发育比较,我们在临床分离株中观察到gG-1基因的两种(主要)遗传变异,分别对应于与抗gG-1 MAb的反应性或无反应性。此外,有4株毒株似乎是这两种gG-1变异体的重组体。另外,有1株毒株由于移码突变(以插入一个胞嘧啶核苷酸的形式)呈现gG-1阴性表型。当研究感染这两种变异体之一的患者血清中针对HSV-1的免疫球蛋白G反应性时,在通用型酶联免疫吸附测定(ELISA)或基于gG-1型特异性抗原的ELISA中,两组之间均未发现显著差异。尽管本文记录了影响该蛋白免疫显性区域的gG-1基因存在两种变异体,但可能需要寻找其他情况,如感染早期阶段,来解释在一部分HSV-1感染患者中常见的对gG-1血清学阴性现象。